Research and Scientific Development

The Research and Scientific Development team at Artios Pharma is dedicated to advancing innovative cancer therapies by focusing on the DNA Damage Response (DDR). This multidisciplinary team collaborates on early research, preclinical studies, and the translation of scientific insights into actionable treatment strategies, leveraging expertise in biology, bioinformatics, pharmacology, and analytical chemistry to drive the next generation of cancer treatments.